| Buddy R Nielsen, MD | |
|
1501 E Mockingbird Ln, #101, Victoria, TX 77904-2155 | |
| (361) 573-6291 | |
| (361) 576-2434 |
| Full Name | Buddy R Nielsen |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 33 Years |
| Location | 1501 E Mockingbird Ln, Victoria, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114007051 | NPI | - | NPPES |
| 138596501 | Medicaid | TX | |
| MDJ8074 | Other | TX | WORKER COMPENSATION |
| 742710179A012 | Other | TX | CHAMPUS |
| 87W152 | Other | TX | BLUE CROSS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | J8074 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Citizens Medical Center | Victoria, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Citizens Medical Center County Of Victoria | 3577785096 | 85 |
News Archive
Researchers at the University of Illinois at Chicago College of Medicine have shown for the first time how the activation of a receptor provokes the inflammation and bone degradation of rheumatoid arthritis - and that activation of this one receptor, found on cells in the fluid of arthritic joints, is all that is required.
Raptor Pharmaceuticals Corp. has announced that its clinical development subsidiary, Bennu Pharmaceuticals Inc. , has initiated the Company's first clinical-stage program after dosing the first cohort in a Phase IIa study of oral 4-methylpyrazole ("4-MP") in subjects with ALDH2 deficiency, or ethanol intolerance, as the initial development stage of its Convivia program.
A recent study demonstrating that the treatment of nasolabial folds with Restylane positively influences the first impression that an individual projects was published by Dr. Steven Dayan (www.drdayan.com) and DeNova research in the November 2010 issue of Dermatologic Surgery, a leading Dermatology journal. In a study 20 patients received Restylane the popular hyaluronic filler to fill in the nasolabial folds which run from the side of the nose to the side of the mouth.
Dyax Corp. announced today new developments involving drug candidates identified using the Company's proprietary phage display technology as a result of two deals recently announced by sanofi-aventis.
› Verified 8 days ago
| Entity Name | Victoria Anesthesiology Assoc Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881709780 PECOS PAC ID: 5395636716 Enrollment ID: O20040323001880 |
News Archive
Researchers at the University of Illinois at Chicago College of Medicine have shown for the first time how the activation of a receptor provokes the inflammation and bone degradation of rheumatoid arthritis - and that activation of this one receptor, found on cells in the fluid of arthritic joints, is all that is required.
Raptor Pharmaceuticals Corp. has announced that its clinical development subsidiary, Bennu Pharmaceuticals Inc. , has initiated the Company's first clinical-stage program after dosing the first cohort in a Phase IIa study of oral 4-methylpyrazole ("4-MP") in subjects with ALDH2 deficiency, or ethanol intolerance, as the initial development stage of its Convivia program.
A recent study demonstrating that the treatment of nasolabial folds with Restylane positively influences the first impression that an individual projects was published by Dr. Steven Dayan (www.drdayan.com) and DeNova research in the November 2010 issue of Dermatologic Surgery, a leading Dermatology journal. In a study 20 patients received Restylane the popular hyaluronic filler to fill in the nasolabial folds which run from the side of the nose to the side of the mouth.
Dyax Corp. announced today new developments involving drug candidates identified using the Company's proprietary phage display technology as a result of two deals recently announced by sanofi-aventis.
› Verified 8 days ago
| Entity Name | Citizens Medical Center County Of Victoria |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205242088 PECOS PAC ID: 3577785096 Enrollment ID: O20141117000499 |
News Archive
Researchers at the University of Illinois at Chicago College of Medicine have shown for the first time how the activation of a receptor provokes the inflammation and bone degradation of rheumatoid arthritis - and that activation of this one receptor, found on cells in the fluid of arthritic joints, is all that is required.
Raptor Pharmaceuticals Corp. has announced that its clinical development subsidiary, Bennu Pharmaceuticals Inc. , has initiated the Company's first clinical-stage program after dosing the first cohort in a Phase IIa study of oral 4-methylpyrazole ("4-MP") in subjects with ALDH2 deficiency, or ethanol intolerance, as the initial development stage of its Convivia program.
A recent study demonstrating that the treatment of nasolabial folds with Restylane positively influences the first impression that an individual projects was published by Dr. Steven Dayan (www.drdayan.com) and DeNova research in the November 2010 issue of Dermatologic Surgery, a leading Dermatology journal. In a study 20 patients received Restylane the popular hyaluronic filler to fill in the nasolabial folds which run from the side of the nose to the side of the mouth.
Dyax Corp. announced today new developments involving drug candidates identified using the Company's proprietary phage display technology as a result of two deals recently announced by sanofi-aventis.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Buddy R Nielsen, MD 1501 E Mockingbird Ln, Ste 101, Victoria, TX 77904-2178 Ph: (361) 573-6291 | Buddy R Nielsen, MD 1501 E Mockingbird Ln, #101, Victoria, TX 77904-2155 Ph: (361) 573-6291 |
News Archive
Researchers at the University of Illinois at Chicago College of Medicine have shown for the first time how the activation of a receptor provokes the inflammation and bone degradation of rheumatoid arthritis - and that activation of this one receptor, found on cells in the fluid of arthritic joints, is all that is required.
Raptor Pharmaceuticals Corp. has announced that its clinical development subsidiary, Bennu Pharmaceuticals Inc. , has initiated the Company's first clinical-stage program after dosing the first cohort in a Phase IIa study of oral 4-methylpyrazole ("4-MP") in subjects with ALDH2 deficiency, or ethanol intolerance, as the initial development stage of its Convivia program.
A recent study demonstrating that the treatment of nasolabial folds with Restylane positively influences the first impression that an individual projects was published by Dr. Steven Dayan (www.drdayan.com) and DeNova research in the November 2010 issue of Dermatologic Surgery, a leading Dermatology journal. In a study 20 patients received Restylane the popular hyaluronic filler to fill in the nasolabial folds which run from the side of the nose to the side of the mouth.
Dyax Corp. announced today new developments involving drug candidates identified using the Company's proprietary phage display technology as a result of two deals recently announced by sanofi-aventis.
› Verified 8 days ago
Mr. Jeffrey Fred Davang, CRNA Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1501 E Mockingbird Ln, 101, Victoria, TX 77904 Phone: 361-573-2481 Fax: 361-576-2434 | |
Indrani Dorai Swami, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1501 E Mockingbird Ln, #101, Victoria, TX 77904 Phone: 361-513-6291 Fax: 361-576-2434 | |
Dr. Kapil Kashyap, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1501 E Mockingbird Ln Ste 101, Victoria, TX 77904 Phone: 361-573-6291 Fax: 361-576-2434 | |
Dr. Robert Gene Jantz, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2701 Hospital Dr, Victoria, TX 77901 Phone: 361-573-6291 Fax: 361-576-2434 | |
Juan Manuel Gonzalez, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 325 Kendal Dr, Victoria, TX 77904 Phone: 361-541-6018 | |
Stephen E Janecek, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1501 E Mockingbird Lane, #200, Victoria, TX 77904 Phone: 316-573-6291 Fax: 361-576-2434 |